Mal-PEG8-Val-Cit-PAB-MMAF, a drug-linker conjugate utilized for antibody-drug conjugates (ADCs), includes a cleavable linker system and the potent tubulin inhibitor monomethyl auristatin F (MMAF), designed for targeted cancer therapy.
Molecular Weight:
1640.95
Formula:
C81H129N11O24
Target:
Drug-Linker Conjugates for ADC
* VAT and and shipping costs not included. Errors and price changes excepted
